This grant from the National Heart, Lung, and Blood Institute aims to provide long-term support to experienced investigators with outstanding research records in heart, lung, blood, and sleep research. The award supports a research program for up to seven years, allowing investigators the freedom to pursue innovative and high-risk research within the scope of NHLBI’s mission. Applicants must be current PD/PIs on at least two NHLBI R01-equivalent awards to be eligible for this grant, which aims to promote scientific productivity and advancements in the field.
Opportunity ID: 333315
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-HL-23-005 |
Funding Opportunity Title: | NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 20 |
Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 05, 2021 |
Last Updated Date: | May 05, 2021 |
Original Closing Date for Applications: | Apr 25, 2024 |
Current Closing Date for Applications: | Apr 25, 2024 |
Archive Date: | May 31, 2024 |
Estimated Total Program Funding: | $20,000,000 |
Award Ceiling: | $700,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Private institutions of higher education Independent school districts State governments Native American tribal governments (Federally recognized) County governments Small businesses Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses City or township governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The EIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards. The EIA will support the research program of NHLBI-funded investigators for up to seven years. The EIA will provide investigators increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. It will also allow PD/PIs to take greater risks and to pursue research that requires a longer timeframe. Research supported by the EIA must be within the scope of the NHLBI mission (http://www.nhlbi.nih.gov/about/org/mission). |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-005.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 333315 Full Announcement-RFA-HL-23-005 -> RFA-HL-23-005-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270794 | Jan 15, 2022 | Jan 24, 2023 | View | |
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00266933 | Jan 15, 2022 | Jan 24, 2022 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278293 | Nov 10, 2022 | Apr 25, 2024 | View |
Package 1
Mandatory forms
333315 RR_SF424_5_0-5.0.pdf
333315 PHS398_CoverPageSupplement_5_0-5.0.pdf
333315 RR_OtherProjectInfo_1_4-1.4.pdf
333315 PerformanceSite_4_0-4.0.pdf
333315 RR_KeyPersonExpanded_4_0-4.0.pdf
333315 RR_Budget10_3_0-3.0.pdf
333315 PHS398_ResearchPlan_4_0-4.0.pdf
333315 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
333315 RR_SubawardBudget10_30_3_0-3.0.pdf
333315 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
333315 RR_SF424_2_0-2.0.pdf
333315 PHS398_CoverPageSupplement_5_0-5.0.pdf
333315 RR_OtherProjectInfo_1_4-1.4.pdf
333315 PerformanceSite_2_0-2.0.pdf
333315 RR_KeyPersonExpanded_2_0-2.0.pdf
333315 RR_Budget10_1_4-1.4.pdf
333315 PHS398_ResearchPlan_4_0-4.0.pdf
333315 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
333315 RR_SubawardBudget10_30_1_4-1.4.pdf
333315 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
333315 RR_SF424_5_0-5.0.pdf
333315 PHS398_CoverPageSupplement_5_0-5.0.pdf
333315 RR_OtherProjectInfo_1_4-1.4.pdf
333315 PerformanceSite_4_0-4.0.pdf
333315 RR_KeyPersonExpanded_4_0-4.0.pdf
333315 RR_Budget10_3_0-3.0.pdf
333315 PHS398_ResearchPlan_5_0-5.0.pdf
333315 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
333315 RR_SubawardBudget10_30_3_0-3.0.pdf
333315 PHS_AssignmentRequestForm_3_0-3.0.pdf